Skip to content

CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved. CFDs are leveraged products. CFD trading may not be suitable for everyone and can result in losses that exceed your deposits, so please ensure that you fully understand the risks involved.

Nearmap share price down 30% in a month: where next?

As investors continue to sell-down the stock, we examine Nearmap’s first-half results, FY20 guidance and the view of one bullish broker.

Nearmap share price comes under pressure Source: Bloomberg

Nearmap share price still under pressure

Though Nearmap’s (ASX: NEA) first-half results carried with it the following headline: 'uniquely positioned for global market opportunity,’ the fast-growing aerial imaging company proved to be one of the worst performing stocks on the Aussie market today, being bid down as much as 7.6% during the session.

The Nearmap share price finished out the session at the $1.83 mark.

Ultimately, this caps off a tumultuous month for the company: with its share price now down ~30% in the last 30 days.

Do you own NEA shares? You can hedge your downside risk by trading CFDs now.

As part of Nearmap’s half-yearly results, the company reported Annualised Contract Values of $96.6 million – representing growth of 23% over the prior comparative period.

This translated to a 31% increase in statutory revenues – with these sales coming in at $46.3 million for the half. In the first-half of FY19, by comparison, Group revenues stood at $35.5 million.

Finally, the company also showed an increase in the Group Average Revenue Per Subscription (ARPS). Here, the company noted that Global Subscriptions increased 8% – to 10,081 overall – while the ARPS grew an impressive 14%.

In saying all this, it should be noted that NEA remains loss making, reporting a H1 statutory loss after tax of $18.6 million.

Regardless of all this and commenting on these results, Nearmap’s CEO, Dr Rob Newman said:

'Our investment into Sales & Marketing in North America was validated by a strong and improved performance from the North American core business.'

'While movements in larger contracts continue to disproportionality influence performance, as we continue to growth the repeatable, scalable core business in that region, our portfolio will become less impacted by these larger customers.'

The outlook: where next for Nearmap?

Nearmap’s CEO maintained that the company’s fundamentals and the opportunity at hand over the medium to long-term remains positive.

'Last month we revised guidance for our FY20 ACV Group portfolio to between $102m-$110m, and to continue to deliver ACV growth of 20-40% in the medium to long term,’ said Dr Rob Newman.

Excitingly, the company further said it would launch 'subscription-based artificial intelligence content’ in the second-half of FY20.

In response to today's results, the Royal Bank of Canada's Sydney Branch reiterated their Outperform rating on the stock as well as a lofty price target of $4.00 per share.

Click here now to open an IG Trading Account today.

IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.

No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.

Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

Seize a share opportunity today

Go long or short on thousands of international stocks.

  • Increase your market exposure with leverage
  • Get spreads from just 0.1% on major global shares
  • Trade CFDs straight into order books with direct market access

Live prices on most popular markets

  • Forex
  • Shares
  • Indices

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.

The Momentum Report

Get the week’s momentum report sent directly to your inbox every Monday for FREE. The Week Ahead gives you a full calendar of upcoming key events to monitor in the coming week, as well as commentary and insight from our expert analysts on the major indices to watch.

For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.